235 related articles for article (PubMed ID: 35911902)
1. A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion.
Purja S; Oh S; Kim E
Front Neurol; 2022; 13():887164. PubMed ID: 35911902
[TBL] [Abstract][Full Text] [Related]
2. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
3. Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis.
Ganesh A; Reis IR; Varma M; Patry DG; Cooke LJ
Can J Neurol Sci; 2022 Jul; 49(4):514-531. PubMed ID: 34287109
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid in COVID-19: A systematic review of the literature.
Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR
J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review.
Lewis A; Frontera J; Placantonakis DG; Galetta S; Balcer L; Melmed KR
Clin Neurol Neurosurg; 2021 Aug; 207():106760. PubMed ID: 34146842
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2.
Lewis A; Jain R; Frontera J; Placantonakis DG; Galetta S; Balcer L; Melmed KR
J Neuroimaging; 2021 Sep; 31(5):826-848. PubMed ID: 34105198
[TBL] [Abstract][Full Text] [Related]
7. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
Ermis U; Rust MI; Bungenberg J; Costa A; Dreher M; Balfanz P; Marx G; Wiesmann M; Reetz K; Tauber SC; Schulz JB
Neurol Res Pract; 2021 Mar; 3(1):17. PubMed ID: 33712089
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
Romoli M; Jelcic I; Bernard-Valnet R; García Azorín D; Mancinelli L; Akhvlediani T; Monaco S; Taba P; Sellner J;
Eur J Neurol; 2020 Sep; 27(9):1712-1726. PubMed ID: 32503088
[TBL] [Abstract][Full Text] [Related]
9. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
Li YC; Zhang Y; Tan BH
J Med Virol; 2021 Jul; 93(7):4247-4257. PubMed ID: 33724490
[TBL] [Abstract][Full Text] [Related]
10. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
Wang H; Zhang Z; Zhou J; Han S; Kang Z; Chuang H; Fan H; Zhao H; Wang L; Ning Y; Sarapultsev A; Li WX; Li J; Lin Z; Luo S; Xiong N; Hu D
Front Immunol; 2021; 12():782731. PubMed ID: 34956212
[TBL] [Abstract][Full Text] [Related]
11. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
Javed A
CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
13. Review article on COVID-19 and Guillain-Barré syndrome.
Patnaik UJ
Front Biosci (Schol Ed); 2021 Jun; 13(1):97-104. PubMed ID: 34256532
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Neurological Presentations of Coronavirus Disease in Patients Presenting to a Tertiary Care Hospital During the 2019 Coronavirus Disease Pandemic.
Iltaf S; Fatima M; Salman S; Salam JU; Abbas S
Cureus; 2020 Aug; 12(8):e9846. PubMed ID: 32953353
[TBL] [Abstract][Full Text] [Related]
15. Neurologic Compromise in COVID-19: A Literature Review.
Jardim Vaz de Mello L; Guimaraes Silva E; Oliveira Correa Rabelo G; Evaristo Leite M; Vieira NR; Bahadori M; Seifi A; Godoy DA
J Neurol Res; 2020 Oct; 10(5):164-172. PubMed ID: 33984100
[TBL] [Abstract][Full Text] [Related]
16. [Subtle and subclinical neurological findings in patients with SARS-CoV-2].
Martínez-Piña DA; San Juan-Orta D; González-Guevara E; Vázquez-Díaz CE; Hernández-González MA; Sosa-Ramos JO
Rev Med Inst Mex Seguro Soc; 2023 Nov; 61(6):767-775. PubMed ID: 37995329
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2: is there neuroinvasion?
McQuaid C; Brady M; Deane R
Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 associated nervous system manifestations.
Khatoon F; Prasad K; Kumar V
Sleep Med; 2022 Mar; 91():231-236. PubMed ID: 34321155
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular presentations in patients with COVID-19.
Paliwal VK; Garg RK; Gupta A; Tejan N
Neurol Sci; 2020 Nov; 41(11):3039-3056. PubMed ID: 32935156
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
